Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.00
+0.55 (4.09%)
At close: Jun 26, 2026, 4:00 PM EDT
14.55
+0.55 (3.93%)
After-hours: Jun 26, 2026, 5:47 PM EDT
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Enanta Pharmaceuticals stock have an average target of 19.67, with a low estimate of 19 and a high estimate of 20. The average target predicts an increase of 40.50% from the current stock price of 14.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Enanta Pharmaceuticals stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +42.86% | Jun 23, 2026 |
Unknown Analyst Rodman & Renshaw No rating | Rodman & Renshaw | Buy Initiates $20 | Buy | Initiates | $20 | +42.86% | Mar 26, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $19 | Buy | Maintains | $19 | +35.71% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
67.69M
from 65.32M
Increased by 3.62%
Revenue Next Year
67.86M
from 67.69M
Increased by 0.25%
EPS This Year
-1.94
from -3.84
EPS Next Year
-1.96
from -1.94
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 73.1M | 77.0M | |
| Avg | 67.7M | 67.9M | |
| Low | 61.0M | 53.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.9% | 13.8% | |
| Avg | 3.6% | 0.3% | |
| Low | -6.6% | -21.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.39 | -1.31 | |
| Avg | -1.94 | -1.96 | |
| Low | -2.27 | -3.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.